The current evidence regarding covid‐19 and pregnancy: Where are we now and where should we head to next?
Ημερομηνία
2021Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Despite the volume of publications dedicated to unraveling the biological characteristics and clinical manifestations of SARS‐CoV‐2, available data on pregnant patients are limited. In the current review of literature, we present an overview on the developmental course, complications, and adverse effects of COVID‐19 on pregnancy. A comprehensive review of the literature was per-formed in PubMed/Medline, Embase, and Cochrane Central databases up to June 2021. This article collectively presents what has been so far reported on the identified critical aspects, namely complications during pregnancy, delivery challenges, neonatal health care, potential routes of viral transmission, including vertical transmission or breastfeeding, along with the risks involved in the vaccination strategy during pregnancy. Despite the fact that we are still largely navigating un-charted territory, the observed publication explosion in the field is unprecedented. The overwhelm-ing need for data is undoubtable, and this serves as the driver for the plethora of publications wit-nessed. Nonetheless, the quality of data sourced is variable. In the midst of the frenzy for reporting on SARS‐CoV‐2 data, monitoring this informational overload is where we should head to next, con-sidering that poor quality research may in fact hamper our attempts to prevail against this unpar-alleled pandemic outbreak. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Effectors of Pregorexia and Emesis among Pregnant Women: A Pilot Study
Gerontidis A., Grammatikopoulou M.G., Tzimos C., Gkiouras K., Taousani E., Athanasiadis L., Goulis D.G. (2022)During pregnancy, women tend to improve their lifestyle habits and refine their dietary intake. Quite often, however, these dietary improvements take an unhealthy turn, with orthorexia nervosa (ON) practices being apparent. ... -
Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR
Sifakis S., Androutsopoulos V.P., Pontikaki A., Velegrakis A., Papaioannou G.I., Koukoura O., Spandidos D.A., Papantoniou N. (2018)Fetal growth restriction (FGR) is a gynecological disorder of varying etiology. In the present study, an expression analysis of pregnancy-associated plasma protein A (PAPPA), pregnancy-associated plasma protein A2 (PAPPA2) ... -
Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis
Lavrentaki A., Thomas T., Subramanian A., Valsamakis G., Thomas N., Toulis K.A., Wang J., Daly B., Saravanan P., Sumilo D., Mastorakos G., Tahrani A.A., Nirantharakumar K. (2019)Aims: Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the leading causes of liver transplantation in the West. This study seeks to examine whether women with gestational diabetes mellitus (GDM) are at increased risk ...